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Summary
In this review we illustrated the case of a woman who 
had perimenstrual exacerbations of Darier-White 
disease. The disease improved markedly with the 
use of continuously administered oral contraceptives. 
This striking improvement without side-effects supports 
the use of oral contraceptives in women with Darier— 
White disease, although its role should be investigated 
further using controlled studies in more patients.
Darier-White disease (keratosis follicularis) is a rare 
dermatosis which is characterized by the presence of 
keratotic papules and plaques, predominantly on the 
skin of the chest, back, scalp and flexures.1 Estimates of 
prevalence range from 1 in 100 000 in Scandinavia to 1 in 
55 000 in England.2 Men and women are equally affected. 
The disease is dominantly inherited, and recently the 
gene for Darier’s disease has been localized to chromo­
some 12.3,4 The disease usually begins between the ages 
of 6 and 20 years, with a peak onset between the ages of 
11 and 15 years.2 The course of the disease is chronic 
and in most cases slowly progressive.5 The activity of the 
disease is influenced by several factors. Many patients 
(71%) state that heat or sweating exacerbate the dis­
ease.1"3 Retinoids are known to be beneficial in the
pregnancy and menopause.2,12,13 The fact that the disease 
often starts at puberty supports this hypothesis.2 The 
disease during pregnancy was described as improving by 
Epsy et al.u In Burge’s series 10 of 52 patients improved
while 26 did not notice any alteration and six patients 
became worse during pregnancy.2 Telang et al. mention 
one case of a woman with Darier’s disease which became 
worse during pregnancy.12 Burge and Wilkinson reported 
that most women were unable to link activity of the 
disease to their menstrual cycle, although 10 women 
(14%) noticed perimenstrual exacerbations.2 Epsy et al. 
reported that all their patients (eight) noticed flares 
during menstruation, ranging from occasionally (three) 
to regularly (four) to severe (one).13 Epsy et al. also 
treated five patients with oral contraceptives. All five 
patients improved, one showing a moderate improvement 
or clearing of the affected areas and four showing almost 
complete clearing.13 Burge and Wilkinson observed that 
oral contraceptives are sometimes helpful in the manage­
ment of Darier’s disease for women who notice peri­
menstrual increases in disease activity.2 Our case showed 
marked improvement with oral anticonceptives. The aim 
of the present communication is to report a case of a 
woman suffering from a severe manifestation of Darier’s 
disease, who proved to have a remarkable improvement 
during treatment with oral contraceptives.
treatment of several disorders of keratinization, including 
Darier’s disease.6"9 Cattano has shown that hyperkerato- Case report 
tic papules in Darier’s disease desquamate seven times * ,
more slowly than normal surrounding skin.10,11 The 
rationale for using retinoic acid includes the promotion 
of exfoliation. Although oral aromatic retinoids help in 
most patients, side-effects seriously restrict the long­
term use of this treatment.
Sex hormones also seem to influence the activity, with 
many women reporting changes during menstruation,
37-year-old white woman had been suffering from 
keratosis follicularis since the age of 11 years. In one 
other family member the disease was also 
The skin of the patient was generally rough. Below her 
breasts and the lower part of her back, the skin showed 
hyperkeratotic papules (Fig. I). Her nails were dys­
trophic. Itching of the skin was a major problem.
At first she was treated with bland emollients.
Correspondence: Prof. Dr P.C.M. van de Kerkhof, 802 Depart- Exacerbations were treated with topical corticosteroids 
ment of Dermatology, University Hospital Nijmegen, PO Box 9101, The skin improved remarkably with topical cortico
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medication and in i also used a sunblock.
m
the year now for over 2 years.
of oral
Discussion
Our paper demonstrates the major 
contraceptives for long-term therapy of Darier’s disease. 
Our case confirms earlier observations suggesting that 
sex hormones may modulate the expression of 
severity in
Although evidence does exist for a
hormonal
the disease begins at 
of oestrogens or progesterone to be involved. Progester­
one may have i
ì. This would
s and improvement with oral anticoncep- 
tives, as progesterone levels are high before menstrua­
tion. With the use of oral contraceptives premenstrual 
peak levels of progesterone are avoided. However, if 
either oestrogens or progesterone would be respons­
ible for exacerbations one would expect an increase of 
the disease during pregnancy and a decrease during 
the menopause. However, such is not the classical 
course of Darier’s disease.
The use of oral contraceptives the serum
level of the sex hormone binding globulin. If the blood
of testosterone lower as a conse
Figure 1. Hyperkcratotic papules of the abdomen. quence of this, a of
It is attractive to
previous state. Treatment with topical retinoids also was 
not helpful.
that a rise of follicle
as an
High blood levels of this hormone occur in episodes
When seen in 1993 she reported that the disease had in which the disease as a rule is worse, such as puberty,
during the first days of each menstruation, the skin 
worsened, and became more fragile, red and painful.
treatment with oral
She
and 
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during
blood 
, for exi
occur
and
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with Marvelon
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r we be effective, as in our patient, 
and s are the steroid and 
the skin thyroid hormone receptor superfamily.H It is of interest
and the skin sex hormones also ï to
Two months after starting- 
improved. The itching had 
seemed to be less fragile, 
not completely clear they were reduced in number and mones specifically bind to the corres
ligands for a
different hoi
m
improved. In the first year 
continuously, after which she
of the skin was intercommunication
the medication interactions is active.15 Ligand
:rs and as :
1 out of 3 months.
: a new com « v s *
munication.
of receptors for other ligands.
not notice any
side-effects of Microgynon 50. She continued to use this
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respond to ligands of the steroid receptor superfamily. 
The present case report suggests that studies on the 
interaction of sex hormones with this signalling' process 
might improve the long-term management of disorders 
of keratinization.
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